Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients.
Symptoms of multiple sclerosis during use of combined hormonal contraception.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.
The Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Multiple Sclerosis.
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Modeling cognition and disease using human glial chimeric mice.
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis.
Sexual dysfunction in patients with multiple sclerosis.
Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil.
Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
Cost-Effectiveness of Escalating to Natalizumab or Switching Among Immunomodulators In Relapsing-Remitting Multiple Sclerosis In Italy.
The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
[Clinical and electrophysiological and molecular genetic characteristics of the course of relapsing-remitting multiple sclerosis.]
Oxidative injury in multiple sclerosis cerebellar grey matter.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.
Adult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease.
Duality of Antidepressants and Neuroprotectants.
Harnessing the integrated stress response for the treatment of multiple sclerosis.
Pages
« first
‹ previous
…
625
626
627
628
629
630
631
632
633
…
next ›
last »